Wednesday, October 8th, 2025

Global Market Commentary October 2025: US Tech Pullback, European Highs, and Asia’s Strong Gains | STI & Equity Insights

Broker Name: OCBC Investment Research
Date of Report: 6 October 2025
Excerpt from OCBC Investment Research report.

  • Global equities pulled back slightly after recent record highs, with tech stocks showing weakness, but major indices still closed the week with solid gains.
  • Healthcare and defensive sectors outperformed in the US, while Europe and Asia saw positive momentum driven by capital inflows and policy expectations.
  • Singapore’s Straits Times Index (STI) rose modestly, with banking and REIT stocks featuring prominently among top market capitalizations and yielding steady dividends.

Report Summary

  • US markets paused their rally, especially in tech, but still ended the week higher, with small caps and healthcare outperforming due to defensive rotation and easing sector worries.
  • European and Asian markets advanced, supported by AI investments, policy optimism, and leadership prospects in Japan.
  • Singapore’s market posted mild gains, with financials, REITs, and selected industrials showing dividend resilience and value.

Above is an excerpt from a report by OCBC Investment Research. Clients of OCBC Investment Research can be the first to access the full report from the OCBC Investment Research website : https://www.ocbc.com/research-portal

CapitaLand Investment trades at 20x forward PE and 1x PB, with a dividend yield of 4.2%.

CapitaLand Investment Report CapitaLand Investment Limited / CLI ($2.87, up $0.02) Executive Leadership Changes: CEO Transition: Simon Treacy, CEO of Private Equity Real Estate, will step down effective October 31, 2024. He will assume...

Tsingtao Brewery, Agricultural Bank of China, Inner Mongolia Yili Industrial Group

Tsingtao Brewery, Agricultural Bank of China, Inner Mongolia Yili Industrial Group 🍺 Tsingtao Brewery (168 HK) – Affected by Consumption Downgrade Recommendation: HOLD Target Price: Not specified Stop Loss: Not specified Date of Recommendation:...

Elon Musk’s Support for Weight-Loss Drugs Could Propel Eli Lilly Stock: Analysts See 40% Upside

A Presidential Boost for GLP-1s? Eli Lilly’s stock, recently hit by postelection volatility, could see a remarkable turnaround, driven in part by high-profile endorsements. Bernstein analysts point to positive signals that suggest the pharmaceutical...